Krystal Biotech buy Chardan Capital
Start price
18.12.24
/
50%
€151.90
Target price
18.12.25
€202.14
Performance (%)
-8.10%
Price
23.09.25
€139.60
Summary
This prediction is currently active. With a performance of -8.10%, the BUY prediction by Chardan_Capital is trending in the wrong direction. This prediction currently runs until 18.12.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 7.302% | 7.302% |
| iShares Core DAX® | 0.578% | -3.336% |
| iShares Nasdaq 100 | 1.654% | 3.795% |
| iShares Nikkei 225® | 1.029% | 4.392% |
| iShares S&P 500 | 1.166% | 2.230% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€118.80
05.08.25
05.08.25
€189.46
05.08.26
05.08.26
17.51%
23.09.25
23.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€125.75
25.07.25
25.07.25
€186.52
25.07.26
25.07.26
11.01%
23.09.25
23.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€116.70
07.05.25
07.05.25
€193.05
07.05.26
07.05.26
19.62%
23.09.25
23.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-18.96%
23.09.25
23.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-15.83%
23.09.25
23.09.25